戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 andom location (so-called KO-plus-transgenic humanization).
2 rine lungs and spleens indicating successful humanization.
3  2.5-A resolution and used as a template for humanization.
4 rent and random location; KO-plus-transgenic humanization.
5 facilitate further antibody optimization and humanization.
6 f immunodeficient mouse strains suitable for humanization.
7 ts were allowed to heal on naive mice before humanization.
8 e changes necessary to regain activity after humanization.
9 and also suggest a possible means of enzyme "humanization."
10                               We present the humanization, affinity maturation, and epitope mapping o
11                    A method for simultaneous humanization and affinity maturation of monoclonal antib
12 uld not be identified by sequential in vitro humanization and affinity muturation strategies.
13                                We report the humanization and characterization of monoclonal antibody
14 the Ebola virus now provides a framework for humanization and development of a postexposure immunothe
15  the immunogenicity of rodent antibodies via humanization and generation of antibodies in transgenic
16 gn strategy could be applied during antibody humanization and library design for in vitro display met
17                          Here, we report the humanization and testing of these antibodies for clinica
18 Here, we present data on the identification, humanization, and in vitro pharmacology of an antidote f
19 ovides a detailed description of our genetic humanization approach, and the companion paper reports t
20 stant regions intact, using a unique in situ humanization approach.
21 rparts at the same genetic location (in situ humanization), but such efforts involved laborious proce
22 oach (i) provides a rapid route for antibody humanization constraining the content of original mouse
23 ht chain Ig loci, by far the largest genetic humanizations ever described.
24                                              Humanization had as a consequence that efficacy studies
25 notransplantation with human immune systems (humanization) has been problematic because C57BL/6 SIRPa
26                     Heretofore, most genetic humanizations have involved disruption of the endogenous
27             One important example of genetic humanization involves mice humanized for their Ig genes,
28 e development of a new strategy for antibody humanization is described.
29                   mAb discovery is rapid and humanization is straightforward, establishing the utilit
30  of its high affinity and its high degree of humanization, JC-7U IgG1 is an excellent drug candidate
31  in the CDRs, which are typically avoided in humanization methods.
32                                              Humanization of a potent neutralizing mouse anti-human I
33 y technology, we recently reported the first humanization of a rabbit monoclonal antibody.
34 y either exogenous catestatin replacement or humanization of Chga mice.
35                                              Humanization of E06 was carried out by converting over 6
36   Here we demonstrate marked effects of this humanization of Foxp2 on learning and striatal neuroplas
37          Improvement of affinity, as well as humanization of GNC92H2, would be advantageous in immuno
38 it immune repertoires for the generation and humanization of monoclonal antibodies that bind with str
39                          Here, we report the humanization of mouse 38C2 based on rational design guid
40 hain variable regions (VH), is important for humanization of mouse antibodies.
41             This approach was applied to the humanization of mouse mAb LM609 that is directed to huma
42 designed combinatorial V gene libraries, the humanization of mouse monoclonal antibody LM609 directed
43              In this report, we describe the humanization of muMAb VEGF A.4.6.1. by site-directed mut
44                                          The humanization of rabbit antibodies, however, has not been
45                                              Humanization of rhLCV with EBV gp350 also confers suscep
46 rived from mice bearing human Ig transgenes, humanization of rodent Abs, or phage libraries.
47 ural information and computational tools the humanization of rodent antibodies for clinical use often
48              In addition, we determined that humanization of SCID mice following engraftment and vasc
49  provides a framework for further design and humanization of shark IgNARs.
50               We have applied this method to humanization of the anti-vascular endothelial growth fac
51 es, such as cocaethylene, and for additional humanization of the antibody.
52                                We report the humanization of the glycosylation pathway in the yeast P
53  themes emerged: 1) a feeling of support, 2) humanization of the medical system, 3) an opportunity fo
54 r findings have significant implications for humanization of the mouse IgG1 currently in clinical tri
55                                   Homozygous humanization of TPO led to increased levels of human eng
56 ell-binding antibodies, these data show that humanization offers a significant reduction in immunogen
57                                     Antibody humanization often requires the replacement of key resid
58 tibody-derived antibody sequence used during humanization, only the CDR3 region from a murine antibod
59 hus overcoming the major drawback of current humanization procedures, the requirement to construct an
60 ut these systems involve a long and variable humanization process, are expensive, and require the use
61         The best available methods for liver humanization rely on cell transplantation into immunodef
62 cells and stromal cells occurs 2 weeks after humanization, so investigators should expect to observe
63                                    The novel humanization strategy described here provides a robust a
64 ndogenous epithelium with subsequent stromal humanization takes 1 month.
65 highly successful in the clinic, all current humanization techniques have potential limitations, such
66            The best available model of liver humanization, the uroplasminogen-activator transgenic mo
67 for very large, in situ, and precise genetic humanization using large compound bacterial artificial c
68 e to HCV entry in vitro, we attempted murine humanization via a genetic approach.
69 because of the manner in which their genetic humanization was carried out.
70  immunodeficiency virus, type 1 disease, its humanization was desired to minimize the potential for i
71                                              Humanization was performed by adoptive transfer of human
72                          For rabbit antibody humanization, we then used a selection strategy that com
73                                      Genetic humanization, which involves replacing mouse genes with

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。